Track topics on Twitter Track topics that are important to you
GeneScan Europe AG is a globally operating network of innovative and fast-growing biotechnology companies. The individual subsidiaries’ synergetic areas of activity form the ideal basis for enhancing our products and services in the interests of our customers. The range of products for applied molecular biology that results from this pooled expertise will safeguard our success on the market today and in the future.
Based on its forward-looking biochip technology (BioChipnology®), GeneScan Europe AG offers complete solutions for molecular biological analyses in the fields of agricultural and food industry (Business Unit AgroFood), medical diagnostics (BU Diagnostics), science and research (BU Science).
The key areas of GeneScan Europe AG’s activities include the development, production and sale of customised as well as standardised microarrays. Biochip-based identification systems for organisms and genetic characteristics are already being used and marketed in the AgroFood sector. The company’s many years of experience in the field of food analysis ensures maximum transparency in terms of the identity and quality of foodstuffs and nutritional raw materials. In medical diagnostics, GeneScan biochips are being developed to improve the diagnosis and therapy of disease. Custom-tailored, special chips or standardised application chips that are produced in large series for gene expression studies help customers from the science sector to accelerate the progress of their research projects that are based on ultra-efficient genetic analyses.
The synthesis of biomolecules is also a key area of business for GeneScan Europe AG, which has been established for almost 10 years now and has gained a significant market share in Southern Europe.
GeneScan Europe AG’s core goal is to satisfy customers’ individual wishes. GeneScan does this by providing customers with molecular biological tools such as oligonucleotides and peptides, biochips and the equipment they need to carry out tests and analyses. Comprehensive, expert advice forms just as much part of GeneScan Europe AG’s portfolio as the extensive support we provide for the use of our products in the fields of analysis, diagnostics and research.
Engesserstr. 4 b
From BIO-Europe, the biggest pharma and biotech partnering meeting in Europe, Scrip lists the five hottest topics of discussion and...
(Potsdam Institute for Climate Impact Research (PIK)) Rising temperatures due to greenhouse gas emissions will fundamentally change electricity consumption patterns in Europe. A team of scientists fro...
I interviewed Kate Bingham of SV Health Investors about Alzheimer’s, checkpoint inhibitors, gender diversity and more at BIO Europe. BIO Europe 2017 was off to a racing start on Monday morning w...
By Antonio Parrinello and Steve Scherer CATANIA, Italy (Reuters) - A dozen far-right millennials from Europe and North America plan to set sail next week to "defend Europe" from what they call a migr...
Analysts predict Kymriah could become a $1bn-plus product in Europe
Hackers have caused widespread disruption across Europe, hitting Ukraine especially hard.
Families from across Europe are on Tuesday having their say on an epilepsy drug that raises the risk…
Drug becomes first targeted biologic in Europe to treat moderate-to-severe atopic dermatitis (AP)
Nizatidine Capsules USP Rx only
MANICURE by OPI FINISHING BUTTER
Retavase Reteplase, recombinant
Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...
The proportion of females among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still...
Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years?
The burden of cardiovascular disease is increasing worldwide, which has to be reflected by cardiovascular (CV) research in Europe. CardioScape, a FP7 funded project initiated by the European Society o...
To describe the infrastructural differences in training in Obstetrics and Gynaecology (ObGyn) across Europe.
This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.
This multicenter, prospective, single-arm, phase 3 study will assess the proportion of disease-free patients, starting from administration of the first study treatment to at least 12-month...
The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Eur...
This is a prospective, non-interventional study (NIS) measuring health-related quality of life (HRQoL), treatment satisfaction, and other patient-reported outcomes (PROs) of ADPKD patients...
The main objective is to replicate the validation of omics biomarkers of left ventricular diastolic dysfunction in patients with metabolic syndrome. The aim was to recruit overall 750 pa...
GeneScan is specialized in testing of food, feed and seed for the presence of genetically modified organisms (GMOs). As one of the world's first commercial GMO analytical laboratories GeneScan had a s...
Eurofins GeneScan is the globally recognized leader for the detection for Genetically Modified Organisms (GMOs).Eurofins GeneScan's U.S. laboratory is located in suburban New Orleans, LA. In 1998, the...
GeneScan Europe AG is a globally operating network of innovative and fast-growing biotechnology companies. The individual subsidiaries’ synergetic areas of activity form the ideal basis for enhancin...
Europe Unlimited profiles and connects the community of Europe’s best tech entrepreneurs and international capital through research, networking events and consulting. As such, we are in a position t...
âWe are the gateway to Europe for U.S.-based medical technology companies.â Rick Hughes, President, HealthLink Europe
We have published hundreds of GeneScan Europe AG news stories on BioPortfolio along with dozens of GeneScan Europe AG Clinical Trials and PubMed Articles about GeneScan Europe AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GeneScan Europe AG Companies in our database. You can also find out about relevant GeneScan Europe AG Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Biochips have become an extremely important research tool in the field of life sciences and have found many applications in data-mining, highly parallel genome-wide assays, bioinformatics analysis, clinic diagnostics, sample separation and treatment, and...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...